Canavan disease

Revision as of 03:15, 4 August 2011 by Kristin Feeney (Talk | contribs)

Jump to: navigation, search

For patient information, click here

Canavan disease
ICD-9 330.0
OMIM 271900
DiseasesDB 29780
MedlinePlus 001586

WikiDoc Resources for

Canavan disease

Articles

Most recent articles on Canavan disease

Most cited articles on Canavan disease

Review articles on Canavan disease

Articles on Canavan disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Canavan disease

Images of Canavan disease

Photos of Canavan disease

Podcasts & MP3s on Canavan disease

Videos on Canavan disease

Evidence Based Medicine

Cochrane Collaboration on Canavan disease

Bandolier on Canavan disease

TRIP on Canavan disease

Clinical Trials

Ongoing Trials on Canavan disease at Clinical Trials.gov

Trial results on Canavan disease

Clinical Trials on Canavan disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Canavan disease

NICE Guidance on Canavan disease

NHS PRODIGY Guidance

FDA on Canavan disease

CDC on Canavan disease

Books

Books on Canavan disease

News

Canavan disease in the news

Be alerted to news on Canavan disease

News trends on Canavan disease

Commentary

Blogs on Canavan disease

Definitions

Definitions of Canavan disease

Patient Resources / Community

Patient resources on Canavan disease

Discussion groups on Canavan disease

Patient Handouts on Canavan disease

Directions to Hospitals Treating Canavan disease

Risk calculators and risk factors for Canavan disease

Healthcare Provider Resources

Symptoms of Canavan disease

Causes & Risk Factors for Canavan disease

Diagnostic studies for Canavan disease

Treatment of Canavan disease

Continuing Medical Education (CME)

CME Programs on Canavan disease

International

Canavan disease en Espanol

Canavan disease en Francais

Business

Canavan disease in the Marketplace

Patents on Canavan disease

Experimental / Informatics

List of terms related to Canavan disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Canavan disease is an inherited disorder that causes progressive damage to nerve cells in the brain. This disease is one of a group of genetic disorders called leukodystrophies. Leukodystrophies are characterized by degeneration of myelin, which covers the phospholipid layer of neuron insulating the axon.

Epidemiology

Although Canavan disease may occur in any ethnic group, it affects persons of Eastern European Jewish ancestry more frequently. About 1/40 individuals of Eastern European (Ashkenazi) Jewish ancestry are carriers. Canavan disease is inherited in an autosomal recessive fashion. If both parents are carriers, there is a 25% chance of having an affected child. Genetic counseling and genetic testing is recommended for families who may be carriers.

Cause

Canavan disease is inherited in an autosomal recessive fashion.

Canavan disease is caused by a defective ASPA gene which is responsible for the production of the enzyme aspartoacylase. This enzyme breaks down the concentrated brain molecule N-acetyl aspartate. Decreased aspartoacylase activity prevents the normal breakdown of N-acetyl aspartate, and the lack of breakdown somehow interferes with growth of the myelin sheath of the nerve fibers in the brain. The myelin sheath is the fatty covering surrounding nerve cells that acts as an insulator, and allows for efficient transmission of nerve impulses.

Symptoms

Symptoms of Canavan disease, which appear in early infancy and progress rapidly, may include mental retardation, loss of previously acquired motor skills, feeding difficulties, abnormal muscle tone (i.e., floppiness or stiffness), poor head control, and megalocephaly (abnormally enlarged head). Paralysis, blindness, or seizures may also occur.

Treatment

There is no cure for Canavan disease, nor is there a standard course of treatment. Treatment is symptomatic and supportive. The life expectancy of Canavan patients is not known because new treatments have extended their lives beyond earlier projections. Today, Canavan children often survive into their teens and beyond.

Research involving triacetin supplementation in patients with Canavan disease has shown some promising results. Glyceryl Tricetate study Triacetin, which can be enzymatically cleaved to form acetate, enters the brain more readily than the negatively charged acetate.

Prognosis

Death usually occurs before age 4 untreated, although some children may survive into their twenties via newer treatments which have extended life expectancy. There is no known cure.

Current research

A team of researchers headed by Paola Leone are currently at the University of Medicine and Dentistry of New Jersey, in Camden, New Jersey. The brain gene therapy is conducted at Cooper University Hospital. The procedure involves the insertion of six catheters into the brain that deliver a solution containing 600 billion to 900 billion engineered virus particles. The virus, a modified version of AAV, is designed to replace the aspartoacylase enzyme. Children treated with this procedure to date have shown marked improvements, including the growth of myelin with decreased levels of the n-acetyl-aspartate toxin.

See also

External links

Cost Effectiveness of Canavan disease

| group5 = Clinical Trials Involving Canavan disease | list5 = Ongoing Trials on Canavan disease at Clinical Trials.govTrial results on Canavan diseaseClinical Trials on Canavan disease at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Canavan disease | list6 = US National Guidelines Clearinghouse on Canavan diseaseNICE Guidance on Canavan diseaseNHS PRODIGY GuidanceFDA on Canavan diseaseCDC on Canavan disease


| group7 = Textbook Information on Canavan disease | list7 = Books and Textbook Information on Canavan disease


| group8 = Pharmacology Resources on Canavan disease | list8 = AND (Dose)}} Dosing of Canavan diseaseAND (drug interactions)}} Drug interactions with Canavan diseaseAND (side effects)}} Side effects of Canavan diseaseAND (Allergy)}} Allergic reactions to Canavan diseaseAND (overdose)}} Overdose information on Canavan diseaseAND (carcinogenicity)}} Carcinogenicity information on Canavan diseaseAND (pregnancy)}} Canavan disease in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Canavan disease


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Canavan disease | list9 = AND (pharmacogenomics)}} Genetics of Canavan diseaseAND (pharmacogenomics)}} Pharmacogenomics of Canavan diseaseAND (proteomics)}} Proteomics of Canavan disease


| group10 = Newstories on Canavan disease | list10 = Canavan disease in the newsBe alerted to news on Canavan diseaseNews trends on Canavan disease</small>


| group11 = Commentary on Canavan disease | list11 = Blogs on Canavan disease

| group12 = Patient Resources on Canavan disease | list12 = Patient resources on Canavan diseaseDiscussion groups on Canavan diseasePatient Handouts on Canavan diseaseDirections to Hospitals Treating Canavan diseaseRisk calculators and risk factors for Canavan disease


| group13 = Healthcare Provider Resources on Canavan disease | list13 = Symptoms of Canavan diseaseCauses & Risk Factors for Canavan diseaseDiagnostic studies for Canavan diseaseTreatment of Canavan disease

| group14 = Continuing Medical Education (CME) Programs on Canavan disease | list14 = CME Programs on Canavan disease

| group15 = International Resources on Canavan disease | list15 = Canavan disease en EspanolCanavan disease en Francais

| group16 = Business Resources on Canavan disease | list16 = Canavan disease in the MarketplacePatents on Canavan disease

| group17 = Informatics Resources on Canavan disease | list17 = List of terms related to Canavan disease


}}


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages